N-cadherin mediates angiogenesis by regulating monocyte chemoattractant protein-1 expression via PI3K/Akt signaling in prostate cancer cells

Experimental Cell Research

Volumn 317, Issue 17, 2011, Pages 2512-2521

  Nalla, Arun Kumar ^a   Estes, Norman ^a   Patel, Jitendra ^a   Rao, Jasti S ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Akt; Angiogenesis; Monocyte chemoattractant protein 1; N cadherin

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MONOCYTE CHEMOTACTIC PROTEIN 1; NERVE CELL ADHESION MOLECULE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; UVOMORULIN;

ANGIOGENESIS; ARTICLE; BONE METASTASIS; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER TISSUE; CELL ADHESION; CELL INTERACTION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; PLASMID; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN SECRETION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TISSUE MICROARRAY;

EID: 80052643121     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.07.024     Document Type: Article

References (42)

1. Guarino M., Rubino B., Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology 2007, 39:305-318.
2. Lee T.K., Poon R.T., Yuen A.P., Ling M.T., Kwok W.K., Wang X.H., Wong Y.C., Guan X.Y., Man K., Chau K.L., Fan S.T. Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin. Cancer Res. 2006, 12:5369-5376.
3. Birchmeier C., Birchmeier W., Brand-Saberi B. Epithelial-mesenchymal transitions in cancer progression. Acta Anat. (Basel) 1996, 156:217-226.
4. Hatta K., Takeichi M. Expression of N-cadherin adhesion molecules associated with early morphogenetic events in chick development. Nature 1986, 320:447-449.
5. Bixby J.L., Zhang R. Purified N-cadherin is a potent substrate for the rapid induction of neurite outgrowth. J. Cell Biol. 1990, 110:1253-1260.
6. Navarro P., Ruco L., Dejana E. Differential localization of VE- and N-cadherins in human endothelial cells: VE-cadherin competes with N-cadherin for junctional localization. J. Cell Biol. 1998, 140:1475-1484.
7. Giroldi L.A., Bringuier P.P., Shimazui T., Jansen K., Schalken J.A. Changes in cadherin-catenin complexes in the progression of human bladder carcinoma. Int. J. Cancer 1999, 82:70-76.
8. Mialhe A., Levacher G., Champelovier P., Martel V., Serres M., Knudsen K., Seigneurin D. Expression of E-, P-, n-cadherins and catenins in human bladder carcinoma cell lines. J. Urol. 2000, 164:826-835.
9. Rieger-Christ K.M., Pezza J.A., Dugan J.M., Braasch J.W., Hughes K.S., Summerhayes I.C. Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas. Mol. Pathol. 2001, 54:91-97.
10. Li K., He W., Lin N., Wang X., Fan Q.X. Downregulation of N-cadherin expression inhibits invasiveness, arrests cell cycle and induces cell apoptosis in esophageal squamous cell carcinoma. Cancer Invest. 2010, 28:479-486.
11. Husmark J., Heldin N.E., Nilsson M. N-cadherin-mediated adhesion and aberrant catenin expression in anaplastic thyroid-carcinoma cell lines. Int. J. Cancer 1999, 83:692-699.
12. Hazan R.B., Phillips G.R., Qiao R.F., Norton L., Aaronson S.A. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J. Cell Biol. 2000, 148:779-790.
13. Laskin W.B., Miettinen M. Epithelial-type and neural-type cadherin expression in malignant noncarcinomatous neoplasms with epithelioid features that involve the soft tissues. Arch. Pathol. Lab. Med. 2002, 126:425-431.
14. Derycke L., Morbidelli L., Ziche M., De W.O., Bracke M., Van A.E. Soluble N-cadherin fragment promotes angiogenesis. Clin. Exp. Metastasis 2006, 23:187-201.
15. Gravdal K., Halvorsen O.J., Haukaas S.A., Akslen L.A. A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clin. Cancer Res. 2007, 13:7003-7011.
16. Jennbacken K., Gustavsson H., Welen K., Vallbo C., Damber J.E. Prostate cancer progression into androgen independency is associated with alterations in cell adhesion and invasivity. Prostate 2006, 66:1631-1640.
17. Tran N.L., Nagle R.B., Cress A.E., Heimark R.L. N-cadherin expression in human prostate carcinoma cell lines. An epithelial-mesenchymal transformation mediating adhesion withStromal cells. Am. J. Pathol. 1999, 155:787-798.
18. Salomon D., Ayalon O., Patel-King R., Hynes R.O., Geiger B. Extrajunctional distribution of N-cadherin in cultured human endothelial cells. J. Cell Sci. 1992, 102:7-17.
19. Bussemakers M.J., van B.A., Tomita K., Jansen C.F., Schalken J.A. Complex cadherin expression in human prostate cancer cells. Int. J. Cancer 2000, 85:446-450.
20. Tomita K., van B.A., van Leenders G.J., Ruijter E.T., Jansen C.F., Bussemakers M.J., Schalken J.A. Cadherin switching in human prostate cancer progression. Cancer Res. 2000, 60:3650-3654.
21. Morrissey C., Vessella R.L. The role of tumor microenvironment in prostate cancer bone metastasis. J. Cell. Biochem. 2007, 101:873-886.
22. Lu Y., Chen Q., Corey E., Xie W., Fan J., Mizokami A., Zhang J. Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone. Clin. Exp. Metastasis 2009, 26:161-169.
23. Majumder P.K., Sellers W.R. Akt-regulated pathways in prostate cancer. Oncogene 2005, 24:7465-7474.
24. Li K., Wang X., He W., Lin N., Fan Q.X. Expression of N-cadherin in esophageal squamous cell carcinoma and silencing expression of N-cadherin using RNA interference on invasiveness of EC9706 cells. Ai Zheng 2009, 28:8-13.
25. Jaggi M., Nazemi T., Abrahams N.A., Baker J.J., Galich A., Smith L.M., Balaji K.C. N-cadherin switching occurs in high Gleason grade prostate cancer. Prostate 2006, 66:193-199.
26. Bubendorf L., Schopfer A., Wagner U., Sauter G., Moch H., Willi N., Gasser T.C., Mihatsch M.J. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum. Pathol. 2000, 31:578-583.
27. Ye L., Kynaston H.G., Jiang W.G. Bone metastasis in prostate cancer: molecular and cellular mechanisms (Review). Int. J. Mol. Med. 2007, 20:103-111.
28. Sandig M., Voura E.B., Kalnins V.I., Siu C.H. Role of cadherins in the transendothelial migration of melanoma cells in culture. Cell Motil. Cytoskeleton 1997, 38:351-364.
29. Voura E.B., Sandig M., Siu C.H. Cell-cell interactions during transendothelial migration of tumor cells. Microsc. Res. Tech. 1998, 43:265-275.
30. Jahroudi N., Greenberger J.S. The role of endothelial cells in tumor invasion and metastasis. J. Neurooncol 1995, 23:99-108.
31. Luo Y., Radice G.L. N-cadherin acts upstream of VE-cadherin in controlling vascular morphogenesis. J. Cell Biol. 2005, 169:29-34.
32. Hong K.H., Ryu J., Han K.H. Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A. Blood 2005, 105:1405-1407.
33. Salcedo R., Ponce M.L., Young H.A., Wasserman K., Ward J.M., Kleinman H.K., Oppenheim J.J., Murphy W.J. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 2000, 96:34-40.
34. Niu J., Azfer A., Zhelyabovska O., Fatma S., Kolattukudy P.E. Monocyte chemotactic protein (MCP)-1 promotes angiogenesis via a novel transcription factor, MCP-1-induced protein (MCPIP). J. Biol. Chem. 2008, 283:14542-14551.
35. Larue L., Bellacosa A. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene 2005, 24:7443-7454.
36. Rieger-Christ K.M., Lee P., Zagha R., Kosakowski M., Moinzadeh A., Stoffel J., Ben-Ze'ev A., Libertino J.A., Summerhayes I.C. Novel expression of N-cadherin elicits in vitro bladder cell invasion via the Akt signaling pathway. Oncogene 2004, 23:4745-4753.
37. Wallerand H., Cai Y., Wainberg Z.A., Garraway I., Lascombe I., Nicolle G., Thiery J.P., Bittard H., Radvanyi F., Reiter R.R. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines. Urol. Oncol. 2010, 28:180-188.
38. Testa J.R., Bellacosa A. AKT plays a central role in tumorigenesis. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:10983-10985.
39. Bakin A.V., Tomlinson A.K., Bhowmick N.A., Moses H.L., Arteaga C.L. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem. 2000, 275:36803-36810.
40. Ke A.W., Shi G.M., Zhou J., Huang X.Y., Shi Y.H., Ding Z.B., Wang X.Y., Devbhandari R.P., Fan J. CD151 amplifies signaling by integrin alpha6beta1 to PI3K and induces the epithelial-mesenchymal transition in HCC cells. Gastroenterology 2011, 140:1629-1641.
41. Sosic D., Richardson J.A., Yu K., Ornitz D.M., Olson E.N. Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kappaB activity. Cell 2003, 112:169-180.
42. Wu J., Ru N.Y., Zhang Y., Li Y., Wei D., Ren Z., Huang X.F., Chen Z.N., Bian H. HAb18G/CD147 promotes epithelial-mesenchymal transition through TGF-beta signaling and is transcriptionally regulated by Slug. Oncogene 2011, 10.1038/onc.2011.149.